Fundraising FoxSyensqo Ventures — Full Portfolio
5 tracked investments · listed companies and verified rows first
BioEutectics develops eutectic chemical systems that serve industrial customers across multiple sectors, offering solutions ranging from direct solvent replacements to novel chemical capabilities.
BiotechCleantechFoodTechNew MaterialsTulsa, US
Federico JV Gomez(Founder)inMaria Fernanda Silva(Founder)in
Co-investorsAIR CapitalAtento CapitalGRIDXFen VenturesIndieBioSOSV
DePoly is a Swiss cleantech company developing chemical recycling processes to convert plastic waste back into virgin polymers.
Circular EconomyCleantechNew MaterialsSion, CH
Bardiya Valizadeh(Founder)inChristopher Ireland(Founder)in
Co-investorsBeiersdorf Innovation FundCrane Venture PartnersInfinity RecyclingACE & CompanyAngel InvestBASF Venture Capital GmbH+2 more
ICOMAT builds fully integrated factories that produce steered-fiber composite parts using its patented Rapid Tow Shearing (RTS) process, combining proprietary hardware, software, and production facilities to make lighter, defect-free components at industrial scale.
Advanced ManufacturingHardwareNew MaterialsGloucester, GB
Co-investorsAutotech Ventures8VCDCVC (Data Collective)NATO Innovation Fund
Invizius develops therapeutics targeting the complement system to treat kidney disease and other disorders driven by uncontrolled immune activation.
BiotechDeep TechHealthtechMedical DevicesGlasgow, GB
Dr Magnus Nicolsonin
Co-investorsCalculus Capital Ltd.CalculusMercia VenturesOld College CapitalScottish EnterpriseScottish Investment Bank
Sepion develops advanced polymer separator technology for batteries and other applications including water separation and materials recovery.
CleantechDeep TechEnergyNew MaterialsSilicon Valley, US
Peter Frischmann(CEO & Co-Founder)inBrett Helms(CSO & Co-Founder)in
BoardRandy Chan(Director)
Co-investorsACVC PartnersAlumni VenturesCreative VenturesDolby Family VenturesFine Structures VenturesFoothill Ventures+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.